Urgent.News

600+ sources. One page. See who else covered it.

Editions

Health & Medicine

Lilly sues six companies over alleged illegal sales of experimental obesity drug retatrutide

The lawsuits target a range of businesses that allegedly marketed retatrutide products to consumers despite the drug remaining under clinical development.

We haven't written up this one. CNBC World has the full story — the link below goes straight to it.

Read the original at cnbc.com →

More in Health & Medicine

More from Wednesday 12 August →